日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Correction: Enhancement of the anti-tumor activity of FGFR1 inhibition in squamous cell lung cancer by targeting downstream signaling involved in glucose metabolism

更正：通过靶向葡萄糖代谢相关的下游信号通路，增强FGFR1抑制剂在鳞状细胞肺癌中的抗肿瘤活性

期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.28844
Fumarola, Claudia; Cretella, Daniele; Monica, Silvia La; Bonelli, Mara A; Alfieri, Roberta; Caffarra, Cristina; Quaini, Federico; Madeddu, Denise; Falco, Angela; Cavazzoni, Andrea; Digiacomo, Graziana; Mazzaschi, Giulia; Vivo, Valentina; Barocelli, Elisabetta; Tiseo, Marcello; Petronini, Pier Giorgio; Ardizzoni, Andrea
肺癌
肿瘤
肿瘤免疫
信号转导
代谢
细胞生物学
FGFR1
发表日期：2026
文献求助 收藏

Correction: The anti-tumor efficacy of CDK4/6 Inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cells

更正：CDK4/6抑制剂与PI3K/AKT/mTOR抑制剂联合使用，可通过损害TNBC细胞的葡萄糖代谢来增强其抗肿瘤疗效。

期刊:Journal of Experimental & Clinical Cancer Research
影响因子:12.8
doi:10.1186/s13046-025-03383-x
Cretella, Daniele; Ravelli, Andrea; Fumarola, Claudia; La Monica, Silvia; Digiacomo, Graziana; Cavazzoni, Andrea; Alfieri, Roberta; Biondi, Alessandra; Generali, Daniele; Bonelli, Mara; Petronini, Pier Giorgio
CDK4
肿瘤
mTOR
肿瘤免疫
代谢
细胞生物学
AKT
发表日期：2025
文献求助 收藏

Correction: Cavazzoni et al. Pemetrexed Enhances Membrane PD-L1 Expression and Potentiates T Cell-Mediated Cytotoxicity by Anti-PD-L1 Antibody Therapy in Non-Small-Cell Lung Cancer. Cancers 2020, 12, 666

更正：Cavazzoni 等人，《培美曲塞增强膜 PD-L1 表达并增强抗 PD-L1 抗体疗法在非小细胞肺癌中的 T 细胞介导的细胞毒性》，Cancers 2020, 12, 666

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17081254
Cavazzoni, Andrea; Digiacomo, Graziana; Alfieri, Roberta; La Monica, Silvia; Fumarola, Claudia; Galetti, Maricla; Bonelli, Mara; Cretella, Daniele; Barili, Valeria; Zecca, Alessandra; Giovannetti, Elisa; Fiorentino, Michelangelo; Tiseo, Marcello; Petronini, Pier Giorgio; Ardizzoni, Andrea
毒理研究
细胞生物学
PD-L1
肺癌
肿瘤
肿瘤免疫
T细胞
发表日期：2025
文献求助 收藏

Dual Inhibition of CDK4/6 and PI3K/AKT/mTOR Signaling Impairs Energy Metabolism in MPM Cancer Cells

CDK4/6 和 PI3K/AKT/mTOR 信号通路的双重抑制会损害 MPM 癌细胞的能量代谢

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms21145165
Bonelli, Mara; Terenziani, Rita; Zoppi, Silvia; Fumarola, Claudia; La Monica, Silvia; Cretella, Daniele; Alfieri, Roberta; Cavazzoni, Andrea; Digiacomo, Graziana; Galetti, Maricla; Petronini, Pier Giorgio
CDK4
肿瘤
mTOR
肿瘤免疫
信号转导
代谢
细胞生物学
AKT
发表日期：2020
文献求助 收藏

Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC

第三代 EGFR 抑制剂奥希替尼联合培美曲塞或顺铂在 EGFR 突变型非小细胞肺癌临床前模型中具有持久的抗肿瘤作用。

期刊:Journal of Experimental & Clinical Cancer Research
影响因子:12.8
doi:10.1186/s13046-019-1240-x
La Monica, Silvia; Minari, Roberta; Cretella, Daniele; Flammini, Lisa; Fumarola, Claudia; Bonelli, Mara; Cavazzoni, Andrea; Digiacomo, Graziana; Galetti, Maricla; Madeddu, Denise; Falco, Angela; Lagrasta, Costanza Annamaria; Squadrilli, Anna; Barocelli, Elisabetta; Romanel, Alessandro; Quaini, Federico; Petronini, Pier Giorgio; Tiseo, Marcello; Alfieri, Roberta
肺癌
肿瘤
肿瘤免疫
EGF
EGFR
细胞生物学
发表日期：2019
文献求助 收藏

Trastuzumab emtansine delays and overcomes resistance to the third-generation EGFR-TKI osimertinib in NSCLC EGFR mutated cell lines

曲妥珠单抗-美坦新可延缓并克服非小细胞肺癌EGFR突变细胞系对第三代EGFR-TKI奥希替尼的耐药性。

期刊:Journal of Experimental & Clinical Cancer Research
影响因子:12.8
doi:10.1186/s13046-017-0653-7
La Monica, Silvia; Cretella, Daniele; Bonelli, Mara; Fumarola, Claudia; Cavazzoni, Andrea; Digiacomo, Graziana; Flammini, Lisa; Barocelli, Elisabetta; Minari, Roberta; Naldi, Nadia; Petronini, Pier Giorgio; Tiseo, Marcello; Alfieri, Roberta
肺癌
肿瘤
肿瘤免疫
EGF
EGFR
细胞生物学
发表日期：2017
文献求助 收藏

Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells.

CDK4/6 和 PI3K/AKT/mTOR 通路的联合抑制可对恶性胸膜间皮瘤细胞产生协同抗肿瘤作用

期刊:Neoplasia
影响因子:7.7
doi:10.1016/j.neo.2017.05.003
Bonelli Mara A, Digiacomo Graziana, Fumarola Claudia, Alfieri Roberta, Quaini Federico, Falco Angela, Madeddu Denise, La Monica Silvia, Cretella Daniele, Ravelli Andrea, Ulivi Paola, Tebaldi Michela, Calistri Daniele, Delmonte Angelo, Ampollini Luca, Carbognani Paolo, Tiseo Marcello, Cavazzoni Andrea, Petronini Pier Giorgio
细胞生物学
肿瘤
PI3K/Akt
mTOR
肿瘤免疫
发表日期：2017
文献求助 收藏

Enhancement of the anti-tumor activity of FGFR1 inhibition in squamous cell lung cancer by targeting downstream signaling involved in glucose metabolism.

通过靶向葡萄糖代谢相关的下游信号通路，增强 FGFR1 抑制剂在鳞状细胞肺癌中的抗肿瘤活性

期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.19279
Fumarola Claudia, Cretella Daniele, La Monica Silvia, Bonelli Mara A, Alfieri Roberta, Caffarra Cristina, Quaini Federico, Madeddu Denise, Falco Angela, Cavazzoni Andrea, Digiacomo Graziana, Mazzaschi Giulia, Vivo Valentina, Barocelli Elisabetta, Tiseo Marcello, Petronini Pier Giorgio, Ardizzoni Andrea
代谢
信号转导
细胞生物学
肿瘤
肺癌
肿瘤免疫
发表日期：2017
文献求助 收藏

Trastuzumab emtansine is active on HER-2 overexpressing NSCLC cell lines and overcomes gefitinib resistance

曲妥珠单抗-美坦新对HER-2过表达的非小细胞肺癌细胞系有效，并能克服吉非替尼耐药性。

期刊:Molecular Cancer
影响因子:33.9
doi:10.1186/1476-4598-13-143
Cretella, Daniele; Saccani, Francesca; Quaini, Federico; Frati, Caterina; Lagrasta, Costanza; Bonelli, Mara; Caffarra, Cristina; Cavazzoni, Andrea; Fumarola, Claudia; Galetti, Maricla; La Monica, Silvia; Ampollini, Luca; Tiseo, Marcello; Ardizzoni, Andrea; Petronini, Pier Giorgio; Alfieri, Roberta R
肿瘤免疫
肺癌
细胞生物学
肿瘤
发表日期：2014
文献求助 收藏